Furthermore, in neurodegenerative diseases, salivary tau protein and beta-amyloidlevels are being investigated as potential biomarkers for Alzheimer's disease, allowing for early detection and progression monitoring[29]. This evidence concerns the gene MAPT and neurodegenerative disease.